Promimic AB
STO:PRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Promimic AB
Other Operating Expenses
Promimic AB
Other Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Promimic AB
STO:PRO
|
Other Operating Expenses
-kr18.8m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stendorren Fastigheter AB
STO:STEF B
|
Other Operating Expenses
-kr1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Swedish Logistic Property AB
STO:SLP B
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cibus Nordic Real Estate AB (publ)
STO:CIBUS
|
Other Operating Expenses
€1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
FastPartner AB
STO:FPAR A
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Asmodee Group AB
STO:ASMDEE B
|
Other Operating Expenses
-€127.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Promimic AB
Glance View
Promimic AB operates as a holding company that develops and markets implant surface modifications and synthetic bone based on a patented method for production of nano sized hydroxyapatite. The company is headquartered in Moelndal, Vastra Gotalands. The company went IPO on 2022-04-29. The firm manufactures, markets and sells biomaterials for improved osseointegration (bone healing) to the companies in the markets for orthopedic and dental implants. The firm operates primarily in the United States, Europe, and South America, with current product applications in the dental, spine, total joint, extremities, and sports medicine implant markets.
See Also
What is Promimic AB's Other Operating Expenses?
Other Operating Expenses
-18.8m
SEK
Based on the financial report for Dec 31, 2025, Promimic AB's Other Operating Expenses amounts to -18.8m SEK.
What is Promimic AB's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-35%
Over the last year, the Other Operating Expenses growth was 20%. The average annual Other Operating Expenses growth rates for Promimic AB have been -30% over the past three years , -35% over the past five years .